Stay updated on Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.

Latest updates to the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page
- CheckyesterdayChange DetectedUI/formatting updates to the history page, including glossary visibility controls, color-coded highlights for additions and deletions, and revised revision labels (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check8 days agoChange DetectedA new version entry (36) with revision v3.3.4 was added on 2026-01-12, and the prior revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAn added 'Revision: v3.3.3' notice appears in the page footer, and the 'HHS Vulnerability Disclosure' link as well as the older 'Revision: v3.3.2' entry have been removed. These are administrative updates to the site's footer and revision history rather than changes to the study data or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study history page now shows Revision v3.3.2 and no longer shows v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedNotice about lapse in government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check87 days agoChange DetectedThere are no substantive changes to study details or recruitment status between the screenshots; only the page layout and history list appear updated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.